152 related articles for article (PubMed ID: 34692552)
1. Corrigendum: TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma.
Zeng YZ; Zhang YQ; Chen JY; Zhang LY; Gao WL; Lin XQ; Huang SM; Zhang F; Wei XL
Front Oncol; 2021; 11():767805. PubMed ID: 34692552
[TBL] [Abstract][Full Text] [Related]
2. TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma.
Zeng YZ; Zhang YQ; Chen JY; Zhang LY; Gao WL; Lin XQ; Huang SM; Zhang F; Wei XL
Front Oncol; 2021; 11():627713. PubMed ID: 33854967
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum: Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial-Mesenchymal Transition.
Yang B; Chen Q; Wan C; Sun S; Zhu L; Zhao Z; Zhong W; Wang B
Front Oncol; 2022; 12():888600. PubMed ID: 35425696
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum: Contrast-Enhanced CT-Based Radiomics Analysis in Predicting Lymphovascular Invasion in Esophageal Squamous Cell Carcinoma.
Li Y; Yu M; Wang G; Yang L; Ma C; Wang M; Yue M; Cong M; Ren J; Shi G
Front Oncol; 2021; 11():712493. PubMed ID: 34222031
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: Brain Metastases from Esophageal Squamous Cell Carcinoma: Clinical Characteristics and Prognosis.
Xiao L; Mowery YM; Czito BG; Wu Y; Gao G; Zhai C; Wang J; Wang J
Front Oncol; 2022; 12():827810. PubMed ID: 35186759
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum: Chloroquine Inhibits Stemness of Esophageal Squamous Cell Carcinoma Cells Through Targeting CXCR4-STAT3 Pathway.
Yue D; Zhang D; Shi X; Liu S; Li A; Wang D; Qin G; Ping Y; Qiao Y; Chen X; Wang F; Chen R; Zhao S; Wang L; Zhang Y
Front Oncol; 2022; 12():860158. PubMed ID: 35280817
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum: The prognosis value of CONUT and SIS score for recurrent or metastatic esophageal squamous cell carcinoma patients treated with second-line immunotherapy.
Zhao XH; Shen WB; Wang D; Wang HS; Song CY; Deng WZ
Front Oncol; 2023; 13():1347301. PubMed ID: 38148843
[TBL] [Abstract][Full Text] [Related]
8. LncRNA-NEF inhibits proliferation, migration and invasion of esophageal squamous-cell carcinoma cells by inactivating wnt/β-catenin pathway.
Zhang J; Hu SL; Qiao CH; Ye JF; Li M; Ma HM; Wang JH; Xin SY; Yuan ZL
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6824-6831. PubMed ID: 30402846
[TBL] [Abstract][Full Text] [Related]
9. Corrigendum: Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma.
Shi J; Zhang Y; Wang J; Li J; Li Z
Front Oncol; 2020; 10():583499. PubMed ID: 33330061
[TBL] [Abstract][Full Text] [Related]
10. TRPC1 inhibits the proliferation and migration of estrogen receptor-positive Breast cancer and gives a better prognosis by inhibiting the PI3K/AKT pathway.
Zhang LY; Zhang YQ; Zeng YZ; Zhu JL; Chen H; Wei XL; Liu LJ
Breast Cancer Res Treat; 2020 Jul; 182(1):21-33. PubMed ID: 32415497
[TBL] [Abstract][Full Text] [Related]
11. Retraction: Corrigendum: Tan IIA Combined With DDP Inhibits Esophageal Squamous Cell Carcinoma
Frontiers Editorial Office
Front Oncol; 2021; 11():721663. PubMed ID: 34249769
[TBL] [Abstract][Full Text] [Related]
12. Corrigendum: Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach.
Tai YK; Chan KKW; Fong CHH; Ramanan S; Yap JLY; Yin JN; Yip YS; Tan WR; Koh APF; Tan NS; Chan CW; Huang RYJ; Li JZ; Fröhlich J; Franco-Obregón A
Front Oncol; 2022; 12():892408. PubMed ID: 35515135
[TBL] [Abstract][Full Text] [Related]
13. Corrigendum: STAM Prolongs Clear Cell Renal Cell Carcinoma Patients' Survival
Deng T; He Z; Duan X; Gu D; Cai C; Wu W; Liu Y; Zeng G
Front Oncol; 2021; 11():726290. PubMed ID: 34568056
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of
Tang L; Wang L; Yu T; Xu T; Zhang L; Shu Y
Transl Cancer Res; 2022 Jan; 11(1):85-98. PubMed ID: 35261887
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum: Expression of Bioactive Chemerin by Keratinocytes Inhibits Late Stages of Tumor Development in a Chemical Model of Skin Carcinogenesis.
Dubois-Vedrenne I; De Henau O; Robert V; Langa F; Javary J; Al Delbany D; Vosters O; Angelats-Canals E; Vernimmen M; Luangsay S; Wittamer V; Parmentier M
Front Oncol; 2020; 10():977. PubMed ID: 32656083
[TBL] [Abstract][Full Text] [Related]
16. Corrigendum: Dysregulation of miR-375/AEG-1 Axis by Human Papillomavirus 16/18-E6/E7 Promotes Cellular Proliferation, Migration, and Invasion in Cervical Cancer.
Jayamohan S; Kannan M; Moorthy RK; Rajasekaran N; Jung HS; Shin YK; Arockiam AJV
Front Oncol; 2021; 11():694442. PubMed ID: 34055655
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum: Downregulation of HMGA1 Mediates Autophagy and Inhibits Migration and Invasion in Bladder Cancer via miRNA-221/TP53INP1/p-ERK Axis.
Liu X; Zhou Z; Wang Y; Zhu K; Deng W; Li Y; Zhou X; Chen L; Li Y; Xie A; Zeng T; Wang G; Fu B
Front Oncol; 2020; 10():1735. PubMed ID: 33014857
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum: High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma.
Wang X; Xing Z; Chen H; Yang H; Wang Q; Xing T
Front Oncol; 2023; 13():1134139. PubMed ID: 37025598
[TBL] [Abstract][Full Text] [Related]
19. Pseudolaric Acid B Inhibits Proliferation, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma Through Regulating CD147.
Yin Z; Cai H; Wang Z; Jiang Y
Drug Des Devel Ther; 2020; 14():4561-4573. PubMed ID: 33149553
[TBL] [Abstract][Full Text] [Related]
20. Cucurbitacin E inhibits esophageal carcinoma cell proliferation, migration, and invasion by suppressing Rac1 expression through PI3K/AKT/mTOR pathway.
Zhang L; Liang H; Xin Y
Anticancer Drugs; 2020 Sep; 31(8):847-855. PubMed ID: 32568828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
